EHR-embedded OCDT in Breast or GI Cancer

Clinical trial NCT03858712 · COMPLETED

Trial details

NCT number: NCT03858712
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Oral Cancer Directed Therapy Breast Cancer Gastrointestinal Cancer Oral Chemotherapy

Start date: 2019-03-13
Primary completion: 2021-11-23
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.